Test a liver function study drug for people with liver problems
Part of Hormones & metabolism clinical trials.
This study checks how a new tablet moves through the body and if it is safe for people with mild or moderate liver problems compared to people with healthy livers. It might help doctors understand how to dose the drug for people like you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Aged between 18 and 70 years
- Weigh at least 50 kg if a man, 45 kg if a woman, and have a BMI between 19 and 30
- Have either mild or moderate liver problems (called Child-Pugh class A or B) due to conditions like hepatitis, alcohol, or fatty liver disease, and be otherwise stable
- If taking medicine for the liver or other conditions, be on a stable dose for at least 4 weeks before starting and throughout the study
- No history of certain thyroid or pancreas conditions, serious illnesses in the past year, or recent major surgery
- Agree to use reliable birth control (if able to have children) and not donate sperm or eggs for 3 months after the last dose
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new oral medication, Chiglitazar, for people who have both type 2 diabetes and a fatty liver condition called MASH (fatty liver with inflammation and scarring). It aims to see if the drug can help improve liver health and diabetes control.
This research study tests how two experimental drugs (AZD9550 and AZD6234) work in people with different levels of liver function. The goal is to understand whether liver disease changes how the body processes these medications, which may help doctors safely treat patients with liver problems in the future.
This study checks how a new medicine (called NNC0487-0111) moves through the body and how safe it is for people with different levels of liver function. If you have stable liver disease or normal liver function, you might help researchers learn how the medicine works.
This study tests an experimental medication called XTYW007 to see if it is safe and how it works in the body. You would take the pills under close supervision and have your health monitored.
This trial tests an experimental pill called DA-302168S to see if it helps lower blood sugar in people with type 2 diabetes. It is for patients who are already managing their diabetes with metformin or lifestyle changes, and it focuses on safety and effectiveness over about 6 months.
This study looks at how the medicine PF-07328948 is processed by people with different levels of liver function. It includes both healthy people and those with stable liver disease (classified as mild, moderate, or severe). The goal is to see if the liver condition affects how the drug works in the body.
Hear when a new Obesity & Overweight trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.